$CCEP

REG - Coca-Cola EP PLC - Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) repurchased 198,944 ordinary shares from 5-9 October 2026, as part of its EUR 1 billion share buyback programme announced in February 2026. The repurchased shares will be cancelled. CCEP is listed on multiple exchanges, including Euronext Amsterdam, NASDAQ, and the London Stock Exchange, under the symbol CCEP.

Original reporting
Published Oct 12, 2026, 12:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 1:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
REG - Coca-Cola EP PLC - Transactions in Own Shares — source image
Decision brief

The 30-second read

$CCEPNeutralLow
01

Why it matters

This RNS confirms completed repurchases over a specific five-trading-day window and states the repurchased shares will be cancelled. It does not modify the program’s authorization or provide new financial guidance.

02

Market read

Traders may use the update to monitor buyback pace, but it is not a fresh fundamental or policy catalyst.

03

What to watch

The announcement does not disclose average repurchase prices or whether the pace accelerates or decelerates versus prior windows, limiting inference value.

Relevance 4/10Novelty 3/10Timing: today’s RNS update on buyback execution (5-9 Oct)

Background

Coca-Cola Europacific Partners is executing a previously announced share buyback program (announced 17 Feb 2026) with an expected total repurchase up to EUR 1 billion.

Company-level read

Ticker impact

$CCEPNeutralHigh confidence
Context

CCEP reports it bought back 150,000 shares on US venues and 48,944 on London venues from 5-9 Oct, to be cancelled under its EUR 1B program.

Expected impact

Mild support as the market tracks buyback pace, but limited incremental impact versus the already-announced program.

Evidence & confidence

The filing is a standard “transactions in own shares” update with no change to buyback authorization size, timing, or guidance.

Market effects

Minimal spillover to consumer staples peers; this is company-specific capital return execution.

Limited impact beyond UK/EU listed large-cap buyback tracking.

Low, as it does not change global demand, pricing, or macro assumptions.

Counterpoint

Buyback prints can be offset by ongoing dilution or weaker fundamentals, so traders should not treat this as a bullish signal by itself.

Key entities

  • Coca-Cola Europacific Partners plc

    Company confirming own-share purchases under its share buyback programme.

  • Goldman Sachs

    Broker/counterparty through which the repurchases were executed on US and London trading venues.

Related articles

$CCEPMed

UBS reiterates Neutral rating on Coca-Cola Europacific Partners stock

UBS reiterated a Neutral rating on Coca-Cola Europacific Partners (CCEP) with a $107.00 price target, citing 5.4% Q3 organic sales growth forecast. The stock trades at $100.50, above InvestingPro’s Fair Value estimate. UBS expects growth in Europe and Asia Pacific, with potential for raised full-year revenue guidance. CCEP reported H1 2026 revenue of EUR 10.7 billion, up 6.1%, and EPS growth of 10.6%. Analysts have mixed views on its valuation and outlook.

Low

Coca Cola Europacific Partners (ENXTAM:CCEP) Board Exit Leaves Its Undervalued Case In Focus

Coca-Cola Europacific Partners (CCEP) is under scrutiny after independent non-executive director Nathalie Gaveau resigned, prompting a review of board roles. The company's share price is €88.3, down 6.26% over the past month but up 17.42% year-to-date and 116.77% over five years. Analysts suggest CCEP is 8% undervalued with a fair value of €95.68, citing strong long-term growth prospects in emerging markets and digital investments.

$CCEPHigh

Transactions in Own Shares

Coca-Cola Europacific Partners (CCEP) repurchased 403,748 ordinary shares from 7 to 11 September 2026, totaling approximately $43.5 million (USD) and £31.2 million (GBP) on US and London trading venues, respectively. The shares were bought as part of the company's EUR 1 billion share buyback program announced in February 2026. The repurchased shares will be cancelled.

$CCEPHigh

CCEP slips as a fresh Wall Street downgrade adds to valuation concerns

Coca-Cola Europacific Partners (CCEP) fell 3.1% after J.P. Morgan re-initiated coverage with an Underweight rating and a $92 price target, citing valuation concerns and potential slowdown in volume growth. The stock has faced scrutiny due to its premium valuation, despite solid first-half 2026 results. Institutional investors have recently adjusted their positions in CCEP.

$CCEPMedAI 8/10

CCEP (CCEP) Q2 2026 Earnings Call Transcript

Coca-Cola Europacific Partners (CCEP) reported Q2 2026 results on a half-year basis: revenue EUR 10.7B (+6.1%), operating profit EUR 1.5B (+8.1%), operating margin 13.8% (+30 bps), and diluted EPS EUR 2.20 (+10.6%). Free cash flow was EUR 435M in H1; management reaffirmed full-year FCF target of at least EUR 1.7B and completed EUR 600M of a EUR 1B buyback. Risks include Middle East commodity volatility.